The Role of Epidermal Growth Factor Receptor in Cancer and their Application for New Targeted Cancer Therapy

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 6

Abstract

ABSTRACT Epidermal Growth Factor Receptor (EGFR) has central role in cancer therapy because it causes tumour progression in many cases. The EGFR has seven ligands. Each factor that can block this binding, inhibits the intracellular signal transduction and prevents progression of the tumours. Immune system response is the most important factor for suppressing the initial stage of tumour growth and destroying some initial malignant cells, daily. On the other hand, tumours have different mechanisms to hide their antigens and escape from immune system responses. In contrary, tumours use some mechanisms to escape from immune system such as: 1) use of TGF-β to initiate angiogenesis and immune suppression; 2) Induces Treg cell activation to modulate other immune cells; 3) secretion of the prostaglandin E2 to convert T cell into Treg. So, if a superantigen fused to one of the EGFR-ligands, causes the induction of immune system responses against the tumour cells. One of the new methods is based on the use of the fused super antigen with a ligand of the EGFR to inhibit ligand attaching to the EGFR and inducing immune system responses. To achieve this goal, we can block binding of EGFR to their ligands in the extracellular domain by fusing ligands with bacterial superantigens, toxins or cytokines of the viruses and plants that can induce immune system responses and kill malignant cells. So, the fused ligand can both block signal transduction and induce immune system response against malignant cells. In addition, with combining traditional drugs, high efficacy of the tumour treatment can be achieved. The aim of this review is to assess the mentioned strategy for targeting tumours

Authors and Affiliations

Farajolah Maleki, Sadeghifard Noorkhoda, Raheleh Halabian, Elham Behzadi, Abbas Ali Imani Fooladi

Keywords

Related Articles

Effectiveness of Various Endodontic Irrigants on the Micro-Hardness of the Root Canal Dentin: An in vitro Study

Introduction: Irrigating solutions used for the elimination of micro-organisms during root canal preparation may affect the chemical and the physical properties of dentin thereby rendering the tooth more susceptible to f...

Effect of Vitamin D Replacement on Serum TSH in Women with Anti-TPO Positive Sub-clinical Hypothyroidism

ABSTRACT Introduction: The coexistence of Sub-Clinical Hypothyroidism (SCH) and vitamin D deficiency is a common problem and may lead to various clinical disorders. Several genetic studies have shown an association betwe...

Prevalence of Refractive Errors and Number Needed to Screen among Rural High School Children in Southern India: A Cross-sectional Study

Introduction: Avoidable blindness is mainly due to uncorrected refractive errors (URE). School Eye Screening (SES) can be used as an initiative to address this issue. Aim: To determine prevalence of URE and Number Needed...

Dizziness: Smell the Smoke!

ABSTRACT Dizziness in a child is often mistaken for giddiness, vertigo or syncope and at times it is considered equivalent to malingering or foolishness. We hereby report a case of a child whose dizziness stayed neglecte...

Download PDF file
  • EP ID EP525956
  • DOI 10.7860/JCDR/2018/35499.11680
  • Views 71
  • Downloads 0

How To Cite

Farajolah Maleki, Sadeghifard Noorkhoda, Raheleh Halabian, Elham Behzadi, Abbas Ali Imani Fooladi (2018). The Role of Epidermal Growth Factor Receptor in Cancer and their Application for New Targeted Cancer Therapy. Journal of Clinical and Diagnostic Research, 12(6), 1-6. https://europub.co.uk/articles/-A-525956